サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1166586

ファージ療法の世界市場 - 産業規模、シェア、動向、機会、予測：細菌タイプ別、製品別、用途別、地域別（2017年～2027年）

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Bacteria Type, By Product, By Application, and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 118 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

ファージ療法の世界市場 - 産業規模、シェア、動向、機会、予測：細菌タイプ別、製品別、用途別、地域別（2017年～2027年）
出版日: 2022年12月01日
発行: TechSci Research
ページ情報: 英文 118 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のファージ療法市場は、2023年から2027年の予測期間中に目覚ましい成長を遂げると予測されています。

主な要因としては、食品媒介疾患の発生率の増加、抗生物質による感染症、広範な研究開発などが挙げられます。市場の成長を支えるその他の要因としては、食品・飲料産業におけるバクテリオファージの用途拡大、政府投資の増加、大衆の間での意識の高まり、技術の進歩が挙げられます。

当レポートでは、世界のファージ療法市場について調査し、セグメント別の分析、市場力学、企業プロファイルなどの情報を提供しています。

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のファージ療法市場に対するCOVID-19の影響

第5章 VOC (顧客の声)

第6章 臨床試験分析

第7章 世界のファージ療法市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 細菌タイプ別（サルモネラ菌、バクテリオファージ、連鎖球菌、大腸菌、その他）
    • 製品別（経口的摂取、外的摂取、外科的治療）
    • 用途別（人間医学、獣医学、食品・飲料、その他）
    • 企業別（2021年）
    • 地域別
  • 市場マップ

第8章 北米のファージ療法市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 細菌タイプ別
    • 製品別
    • 用途別
    • 国別
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第9章 欧州のファージ療法市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 細菌タイプ別
    • 製品別
    • 用途別
    • 国別
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第10章 アジア太平洋のファージ療法市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 細菌タイプ別
    • 製品別
    • 用途別
    • 国別
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第11章 南米のファージ療法市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 細菌タイプ別
    • 製品別
    • 用途別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第12章 中東・アフリカのファージ療法市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 細菌タイプ別
    • 製品別
    • 用途別
    • 国別
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト
    • トルコ

第13章 市場力学

  • 促進要因
  • 課題

第14章 市場の動向と発展

第15章 競合情勢

  • Armata Pharmaceuticals, Inc.
  • iNtODEWORLD, Inc.
  • Phage International, Inc.
  • Fixed-Phage Limited
  • OCUS BIOSCIENCES, INC.
  • Intralytix, Inc
  • PhagoMed Biopharma GmbH
  • PHAGELUX, INC.
  • Pherecydes Pharma SADIR
  • Adaptive Phage Therapeutics Inc.

第16章 戦略的提言

目次
Product Code: 12984

The global phage therapy market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of foodborne diseases, anti-biotic infections, and extensive research and development. Phages, also known as bacteriophages, are viruses that only kill and selectively target bacteria. They are the most common biological entities found in nature, effectively fighting, and destroying multi-drug-resistant bacteria. They are used to treat or stop bacterial infections in patients' bodies. The other factors supporting the market's growth are, the increasing application of bacteriophage across the food and beverage industry, increasing government investments, rising awareness among the masses, and technological advancements.

High Prevalence Rate of Foodborne Diseases and Anti-Biotic Infections

The rise in the prevalence rate of foodborne diseases and anti-biotic infections across the globe is expected to enhance the market's growth. Foodborne infections are caused by rotten food, as pathogenic bacteria and viruses are present in them. Bacteriophages are extremely specific to target bacteria. Its usage targets a specific bacterial species and significantly reduces off-target effects on the microbiome or human patient, as bacteriophages do not directly affect human cells. According to the WHO, in 2019, forecasted that about 600 million people will become ill and 420,000 will die because of contaminated food resulting in the loss of 33 million healthy life years. Also, according to the Centers for Disease Control and Prevention (CDC), in 2019, approximately 2 million people in the United States will contract an antibiotic-resistant infection, with at least 23,000 people dying every year.

Increasing Investment

Heavy investments to support phage therapy by the government is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government and lead companies across the globe are investing in clinical trials and R&D Activities, which is propelling the growth of the market. For instance, in 2016, the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, was granted US$ 5 Mn for 24 research projects to develop advanced therapies such as bacteriophage therapy and others for the treatment of bacterial infections.

Emergence of e-Commerce

Emergence of e-Commerce is bolstering the growth of the market. Several biotech market players are starting to set up online pharmacies of bacteriophage preparations to make phages and phage therapies available across the globe. For instance, in 2020, Ridgeway, a Digital agency, launched a new e-Commerce website for Optibac probiotics, to build on customer compliance and repeat purchase of phage therapy supplements.

Market Segmentation

The global phage therapy market is segmented into bacteria type, products, application, and company. Based on bacteria type, the market is divided into salmonella, bacteriophage, streptococcus, E.coli, and others. Based on products, the market is divided into oral consumption, external consumption, and surgical treatment. Based on application, the market is segmented into human medicines, veterinary sciences, food & beverage, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of foodborne diseases and anti-biotic infections in the country.

Market Players

Armata Pharmaceuticals, Inc., iNtODEWORLD, Inc., Phage International, Inc., Fixed-Phage Limited, OCUS BIOSCIENCES, INC., Intralytix, Inc, PhagoMed Biopharma GmbH, PHAGELUX, INC., Pherecydes Pharma SADIR, and Adaptive Phage Therapeutics Inc are some of the leading companies operating in the market.

Report Scope:

In this report, global phage therapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Phage Therapy Market, By Bacterial Type:

Salmonella

Bacteriophage

Streptococcus

E.Coli

Others

  • Phage Therapy Market, By Products:

Oral Consumption

External Consumption

Surgical Treatment

  • Phage Therapy Market, By Application:

Human Medicines

Veterinary Sciences

Food & Beverage

Others

  • Phage Therapy Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea

Europe & CIS

  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Phage Therapy Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Phage Therapy Market

5. Voice of Customer

6. Clinical Trials Analysis

7. Global Phage Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others)
    • 7.2.2. By Product (Oral Consumption, External Consumption, Surgical Treatment)
    • 7.2.3. By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others)
    • 7.2.4. By Company (2021)
    • 7.2.5. By Region
  • 7.3. Market Map

8. North America Phage Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Bacteria Type
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Phage Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Bacteria Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Application
    • 8.3.2. Mexico Phage Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Bacteria Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Application
    • 8.3.3. Canada Phage Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Bacteria Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Application

9. Europe Phage Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Bacteria Type
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Europe: Country Analysis
    • 9.3.1. France Phage Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Bacteria Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Application
    • 9.3.2. Germany Phage Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Bacteria Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Application
    • 9.3.3. United Kingdom Phage Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Bacteria Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Application
    • 9.3.4. Italy Phage Therapy Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Bacteria Type
        • 9.3.4.2.2. By Product
        • 9.3.4.2.3. By Application
    • 9.3.5. Spain Phage Therapy Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Bacteria Type
        • 9.3.5.2.2. By Product
        • 9.3.5.2.3. By Application

10. Asia-Pacific Phage Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Bacteria Type
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. Asia-Pacific: Country Analysis
    • 10.3.1. China Phage Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Bacteria Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Application
    • 10.3.2. India Phage Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Bacteria Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Application
    • 10.3.3. Japan Phage Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Bacteria Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Application
    • 10.3.4. South Korea Phage Therapy Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Bacteria Type
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Application
    • 10.3.5. Australia Phage Therapy Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Bacteria Type
        • 10.3.5.2.2. By Product
        • 10.3.5.2.3. By Application

11. South America Phage Therapy Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Bacteria Type
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By Country
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Phage Therapy Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Bacteria Type
        • 11.3.1.2.2. By Product
        • 11.3.1.2.3. By Application
    • 11.3.2. Argentina Phage Therapy Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Bacteria Type
        • 11.3.2.2.2. By Product
        • 11.3.2.2.3. By Application
    • 11.3.3. Colombia Phage Therapy Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Bacteria Type
        • 11.3.3.2.2. By Product
        • 11.3.3.2.3. By Application

12. Middle East and Africa Phage Therapy Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Bacteria Type
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By Country
  • 12.3. MEA: Country Analysis
    • 12.3.1. South Africa Phage Therapy Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Bacteria Type
        • 12.3.1.2.2. By Product
        • 12.3.1.2.3. By Application
    • 12.3.2. Saudi Arabia Phage Therapy Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Bacteria Type
        • 12.3.2.2.2. By Product
        • 12.3.2.2.3. By Application
    • 12.3.3. UAE Phage Therapy Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Bacteria Type
        • 12.3.3.2.2. By Product
        • 12.3.3.2.3. By Application
    • 12.3.4. Egypt Phage Therapy Market Outlook
      • 12.3.4.1. Market Size & Forecast
        • 12.3.4.1.1. By Value
      • 12.3.4.2. Market Share & Forecast
        • 12.3.4.2.1. By Bacteria Type
        • 12.3.4.2.2. By Product
        • 12.3.4.2.3. By Application
    • 12.3.5. Turkey Phage Therapy Market Outlook
      • 12.3.5.1. Market Size & Forecast
        • 12.3.5.1.1. By Value
      • 12.3.5.2. Market Share & Forecast
        • 12.3.5.2.1. By Bacteria Type
        • 12.3.5.2.2. By Product
        • 12.3.5.2.3. By Application

13. Market Dynamics

  • 13.1. Drivers
  • 13.2. Challenges

14. Market Trends & Developments

15. Competitive Landscape

  • 15.1. Armata Pharmaceuticals, Inc.
  • 15.2. iNtODEWORLD, Inc.
  • 15.3. Phage International, Inc.
  • 15.4. Fixed-Phage Limited
  • 15.5. OCUS BIOSCIENCES, INC.
  • 15.6. Intralytix, Inc
  • 15.7. PhagoMed Biopharma GmbH
  • 15.8. PHAGELUX, INC.
  • 15.9. Pherecydes Pharma SADIR
  • 15.10. Adaptive Phage Therapeutics Inc.

16. Strategic Recommendations